Norway· NO-ID_B581B9FE-3F9C-459F-9880-57BE57705C94

Rifadin

A rifampicin product containing rifampicin, registered in Norway by Genzyme. The same ATC class is registered in 18 of our 19 countries.

ATC J04AB02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedRifadinATCJ04AB02REGISTER NO.NO-ID_B581B9FE-3F9C-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Rifampicin is registered in 18 of 19 countries.

Countries holding a registration under ATC J04AB02 (rifampicin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 10 of them publish a price we can compare per daily dose

Rifampicin · ATC J04AB02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rifampicin costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.92 in Italy to $6.35 in France — a ×6.9 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Rifampicin · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • FR France$6.35
  • CH Switzerland$4.70
  • IT Italy$0.92
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Rifampicin
Manufacturer
Genzyme
Country
Norway (NO)
ATC code
J04AB02
ATC class
Rifampicin
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_B581B9FE-3F9C-459F-9880-57BE57705C94
  • no_varenummer
    246186
    120
  • gtin
    8712172001434

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

444 interactions on record for rifampicin.

Graded by severity as the source publishes them — 144 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rifampicin · interactions on record

444 records

  • 144 severe
  • 173 moderate
  • 14 minor
  • 39 info

Most severe, free to view

  • RolapitantA04AD14severe
  • NaloxegolA06AH03severe
  • NaldemedineA06AH05severe
  • EluxadolineA07DA06severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rifampicin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifampicin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Eremfat, Rifoldin
  • Belgium · Rifadine, Rifadine I. V.
  • Bulgaria · Тубоцин
  • Cyprus · Rifasynt, Syntoren
  • Czechia · Benemicin
  • Germany · Eremfat, Eremfat I.V.
  • Denmark · Rimactan
  • Spain · Rifaldin, Rimactán
  • Finland · Rimapen
  • France · Rifadine, Rifadine Iv
  • United Kingdom (Northern Ireland) · Rifadin, Rifampicin Generics Uk
  • Croatia · Rimactan
  • Hungary · Rifamed
  • Ireland · Rifadin, Rifadin Intravenous
  • Iceland · Rimactan
  • Italy · Rifadin
  • Lithuania · Benemicin
  • Luxembourg · Rifadine
  • Latvia · Benemicin
  • Malta · Rifampicyna Tzf
  • Netherlands · Rifadin, Rifampicine Sandoz
  • Poland · Rifampicyna Tzf
  • Portugal · Rifadin, Rimactán
  • Romania · Rifampicină Arena, Sinerdol
  • Sweden · Rimactan
  • Slovakia · Benemicin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1de78886-5f0a-493d-950b-2a9a2a2dc77d
GET /v1/drugs/1de78886-5f0a-493d-950b-2a9a2a2dc77d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Mikstur, suspensjon",
  "source": "fest",
  "status": "A",
  "atc_name": "Rifampicin",
  "merkevare_id": "ID_B581B9FE-3F9C-459F-9880-57BE57705C94",
  "name_form_strength": "Rifadin mikst susp 20 mg/ml",
  "prescription_group": "C"
}

See everything about rifampicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.